David Hering - Jul 5, 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Executive Officer, Director
Signature
/s/ Jane Pritchett Henderson, Attorney-in-Fact
Stock symbol
IVVD
Transactions as of
Jul 5, 2022
Transactions value $
$0
Form type
4
Date filed
7/6/2022, 04:05 PM
Previous filing
Feb 1, 2022
Next filing
Sep 1, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +2M $0.00 2M Jul 5, 2022 Common Stock 2M $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a period of 48 months with the first vesting date occurring on August 5, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney